 | | PATHWAY: mol01100 | |
| Entry |
|
| Name |
Metabolic pathways - Methanobrevibacter olleyae |
| Class |
|
| Pathway map |

|
| Module |
| mol_M00019 | Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine [PATH:mol01100] |
| mol_M00527 | Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine [PATH:mol01100] |
| mol_M00577 | Biotin biosynthesis, BioW pathway, pimelate => pimeloyl-CoA => biotin [PATH:mol01100] |
| mol_M00608 | 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate [PATH:mol01100] |
| mol_M00916 | Pyridoxal phosphate biosynthesis, R5P + glyceraldehyde-3P + glutamine => pyridoxal-P [PATH:mol01100] |
|
| Organism |
Methanobrevibacter olleyae [GN: mol]
|
Related pathway |
| mol00040 | Pentose and glucuronate interconversions |
| mol00051 | Fructose and mannose metabolism |
| mol00053 | Ascorbate and aldarate metabolism |
| mol00130 | Ubiquinone and other terpenoid-quinone biosynthesis |
| mol00250 | Alanine, aspartate and glutamate metabolism |
| mol00260 | Glycine, serine and threonine metabolism |
| mol00270 | Cysteine and methionine metabolism |
| mol00280 | Valine, leucine and isoleucine degradation |
| mol00290 | Valine, leucine and isoleucine biosynthesis |
| mol00330 | Arginine and proline metabolism |
| mol00400 | Phenylalanine, tyrosine and tryptophan biosynthesis |
| mol00520 | Amino sugar and nucleotide sugar metabolism |
| mol00523 | Polyketide sugar unit biosynthesis |
| mol00525 | Acarbose and validamycin biosynthesis |
| mol00541 | Biosynthesis of various nucleotide sugars |
| mol00625 | Chloroalkane and chloroalkene degradation |
| mol00630 | Glyoxylate and dicarboxylate metabolism |
| mol00660 | C5-Branched dibasic acid metabolism |
| mol00710 | Carbon fixation by Calvin cycle |
| mol00760 | Nicotinate and nicotinamide metabolism |
| mol00770 | Pantothenate and CoA biosynthesis |
| mol00900 | Terpenoid backbone biosynthesis |
| mol00999 | Biosynthesis of various plant secondary metabolites |
|
| KO pathway |
|
|
|